CatalystWireBeta

New Aivlosin® marketing authorisations

In brief · summary, not quotable

ECO receives marketing authorisations for Aivlosin in Paraguay, Honduras, Saudi Arabia and Oman.

  • Saudi Arabia poultry market annual growth 5.8%
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your EAH notes

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announces further expansion of Aivlosin®, its market leading antibiotic for the treatment of respiratory and intestinal diseases in pigs and poultry, with new authorisations in Paraguay and Honduras and import permits providing accelerated routes to markets in Saudi Arabia and Oman.

Commercial sales have already begun in Saudi Arabia and Oman, and will largely leverage the Group’s existing commercial infrastructure for Aivlosin®. Saudi Arabia is a substantial poultry market, growing at 5.8% annually and responsible for over half of the region’s animal health market, providing a meaningful commercial opportunity and is being accessed via a special import license.

David Hallas, Chief Executive Officer of ECO Animal Health, said: “These new marketing authorisations will provide an opportunity for us to expand our market leading Aivlosin® franchise, extending our reach into Latin America and establishing a foothold in a key poultry market in the Middle East. Coupled with recent progress in geographies such as South and South East Asia, these authorisations highlight ECO’s growth potential through our core business in addition to our innovative R&D pipeline.”

Cleaned text: letterheads, contacts and legal notices removed. Official copy: FCA National Storage Mechanism ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note